Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis

Abstract

Patients with EA displaying high baseline sIL-15 suffered a more severe disease and received more intensive treatment. Thus, sIL-15 may be a biomarker for patients that are candidates for early and more intensive treatment.